News & Events

FDA allows marketing of first test to identify certain bacteria associated with bloodstream infections

Jun 27, 2012 | FDA.gov

The U.S. Food and Drug Administration announced it has allowed marketing of the first nucleic acid test that can identify 12 different bacterial types known to cause bloodstream infections. The test allows for simultaneous identification of the bacteria and three associated resistance genes in just a few hours after the first sign of bacterial growth. Traditional methods may require two to four days to produce bacterial identification and resistance results.